NeuralFrame Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • NeuralFrame's estimated annual revenue is currently $1.6M per year.(i)
  • NeuralFrame's estimated revenue per employee is $87,000

Employee Data

  • NeuralFrame has 18 Employees.(i)
  • NeuralFrame grew their employee count by 6% last year.

NeuralFrame's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
Co-FounderReveal Email/Phone
3
Head Oncology Sales at NeuralFrameReveal Email/Phone
4
Product Manager OncologyReveal Email/Phone
5
Senior Software EngineerReveal Email/Phone
6
Full Stack Software EngineerReveal Email/Phone
7
Senior Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M80%N/AN/A
#2
$0.1M1-83%N/AN/A
#3
$4.1M35N/AN/AN/A
#4
$3.5M301400%N/AN/A
#5
$2.5M259%N/AN/A
#6
$0.4M5-44%N/AN/A
#7
$0.9M10N/AN/AN/A
#8
$0.5M70%N/AN/A
#9
$2.2M22N/AN/AN/A
#10
$2.3M2310%N/AN/A
Add Company

What Is NeuralFrame?

NeuralFrame is a hybrid learning company focused on providing automated data structuring, coding, and summarization of patient data for healthcare providers. Our company leverages an internally-developed, natural language processing (NLP) approach to extract accurate, relevant, and detailed knowledge from clinical text to impact both the quality and efficiency of the physician workflow. NeuralFrame started in 2017 with two founders: Patrick McNeillie, M.D., Chief Architect, and Kevin Scanlan, Head of Business Development. Both founders take an active role in building and training the analytics platform. NeuralFrame also has a board of advisors to provide general management expertise, covering deep NLP knowledge, clinical oncology, and early-stage software development.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$1.6M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M18N/AN/A
#2
$2.9M18-89%N/A
#3
$2.5M18-18%N/A
#4
$1.2M19-5%N/A
#5
$15M196%N/A